STT vs TARS · P/E 17, rev $7.84B vs rev $336.0M
State Street Corp (STT) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
State Street Corp (STT) is a asset management company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
STT currently screens at market cap $45.02B and trailing P/E 16.5. TARS currently screens at market cap $2.66B.
Not investment advice. Open the STT and TARS stock pages for the full models.
Not investment advice.